Randomized phase II trial of the neurokinin-1 receptor antagonist (NK-1 RA) casopitant mesylate with ondansetron (ond)/dexamethasone (dex) for chemotherapy-induced nausea/vomiting (CINV) in patients (pts) receiving highly emetogenic chemotherapy (HEC).

被引：0

作者：

Rolski, J.

Ramlau, R.

Dediu, M.

Russo, M. W.

Ross, G. A.

Mather, R. A.

Bandekar, R. R.

Grunberg, S. M.

机构：

[1] Oncol Ctr, Krakow, Poland

[2] Reg Lung Dis Ctr, Poznan, Poland

[3] Inst Oncol, Bucharest, Romania

[4] GlaxoSmithKline Inc, Collegeville, PA USA

[5] Univ Vermont, Burlington, VT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8513

引用

页码：471S / 471S

页数：1